Boys will be boys. We fight, we apologize, and we enjoy some cold ones the next day like nothing happened. That fraternal feeling may never reach some feuding biotech companies, which seem to find the courtroom as familiar as the research lab. At the center of it all is the hormone that defines masculinity itself: testosterone. Feel the irony?
By now you've probably seen a commercial on TV or a full page print ad for AbbVie's (NYSE: ABBV) AndroGel -- the leading testosterone replacement therapy, or TRT, on the market. And you shouldn't expect the marketing barrage to end any time soon. More and more companies are following demographics into the more than $2 billion U.S. market for TRTs, which is expected to grow to $5 billion by 2017 -- roughly the same size as the erectile dysfunction market today.
Does the rush to resupply the world's manliness amount to opportunity or disaster for AbbVie? It may just depend on your timeline.
First to market, first to fallAbbVie acquired AndroGel in its $6.2 billion acquisition of Solvay Pharmaceuticals in 2010. Given the drug's $1.19 billion in sales last year, the acquisition could more than pay for itself. While the company and analysts expect double digit growth in 2013, the long term success of the franchise -- 1% and 1.62% topical gels -- may hinge on the success of generics eyeing the market. Being the first to market has its advantages, but it also gives your competitors a face to pin to the dart board.
Generic drug manufacturer Perrigo (NASDAQ: PRGO) recently received FDA approval for an AndroGel 1% bioequivalent. The situation got worse for AbbVie a week later when Perrigo filed an Abbreviated New Drug Application for an AndroGel 1.62% bioequivalent, effectively putting the company's entire franchise at risk or future risk. Perrigo will be granted generic exclusivity for 6 months upon FDA approval as the first to file a challenge to AbbVie's patent.
There is more indirect competition for AbbVie to fend off as well. Eli Lilly (NYSE: LLY) has pushed into the testosterone market with muted results thus far. The company's Androderm patch and Axiron topical gel only contributed $135 million to total sales in 2012 hardly a major threat to AndroGel.
Auxilium Pharmaceuticals (NASDAQ: AUXL) enjoyed more success than Eli Lilly with its 1% testosterone gel Testim, which generated $233 in sales last year. Still, sales of the company's TRT only grew 8% compared to 2011. AndroGel grew 31% in 2012. It appears that Perrigo's generic version of AndroGel poses the biggest risk to AbbVie.
Worst-case scenarioLet's be honest -- a lot of things need to go wrong for AndroGel to fall from the leaderboard or not be the market's top-selling drug. AbbVie's targeted marketing campaign has vaulted its TRT well ahead of competing therapies. A more likely scenario would be for growth to slow in the face of a bigger field. In that case, the timing couldn't be worse.
AbbVie is already banking on sales growth from Humira and AndroGel to offset declining drug revenue elsewhere through 2015. By then, the first new pipeline drugs are expected to kick in. If the company's vision of its future is off by just one or two drugs, AbbVie could be headed downhill -- even for just a short time -- when 2015 arrives.
Foolish bottom lineCan AbbVie defend its turf and continue to gain the lion's share of the growth in TRTs? Yes, and it may be able to do so relatively easily. If the market more than doubles by 2017 -- as analysts expect -- there will be more than enough room to accommodate a multitude of therapies. I just wouldn't be so quick to write-off the generic challenge from Perrigo and other maturing products if I was an AbbVie investor. It is a question mark that has yet to be fully accounted for in any growth models or scenarios I have viewed.
Read the rest here:
Will Testosterone Fuel Biotech's Next Great Race?
Contact Us Today For A Free Consultation
- MOTS-c Therapy To Improve Body Composition - December 15th, 2022 [December 11th, 2022]
- Punicalagin: A powerful Testosterone Booster - January 17th, 2023 [November 24th, 2022]
- Blocking Testosterone to Defeat Melanoma - September 9th, 2022 [August 11th, 2022]
- Stomach Inflammation: Another Ailment That Testosterone Can Stop in its Tracks - December 19th, 2022 [August 3rd, 2022]
- Study Finds that Testosterone Boosts Memory for Uncontrolled Diabetics - July 11th, 2022 [June 24th, 2022]
- Causes of Low Libido - Could It Be Low-T? - June 24th, 2022 [May 30th, 2022]
- The Evolutionary Effects of Testosterone on Human Society - November 24th, 2021 [September 20th, 2021]
- More Sex: A Better Way to Boost Your Testosterone Levels - October 30th, 2021 [September 7th, 2021]
- Men Want to Know – Free Testosterone versus Total Testosterone - January 2nd, 2023 [August 24th, 2021]
- What is testosterone? - November 10th, 2021 [May 23rd, 2021]
- Tribulus Terrestris Review Does It Raise Testosterone or ... - May 23rd, 2021 [May 22nd, 2021]
- Boosting testosterone levels (First of two parts) - May 9th, 2021 [May 8th, 2021]
- How long does it take for Testosterone replacement treatments and therapy to work? - November 27th, 2021 [May 1st, 2021]
- What Is Testosterone AndroGel - November 21st, 2021 [April 28th, 2021]
- Low T - My life was falling apart because I had low testosterone - November 20th, 2021 [April 25th, 2021]
- Deer Antler, HGH and Testosterone: Tim on Scott and BR Radio Show - Video - November 27th, 2021 [April 17th, 2021]
- What is Testosterone? What does Testosterone do? Find on - April 14th, 2021 [April 14th, 2021]
- How Testosterone Affects the Skin of Men - November 28th, 2021 [April 11th, 2021]
- Testosterone, the Power Hormone - November 23rd, 2021 [April 8th, 2021]
- Testosterone Levels and Wall Street - October 28th, 2021 [March 27th, 2021]
- Women can resist testosterone-fuelled political debate - March 13th, 2021 [March 12th, 2021]
- BUSTED: Myths About Testosterone And Its Link To Sexual Desire In Men And Women - November 4th, 2021 [March 11th, 2021]
- Attention Baby Boomers -- Could Testosterone be the Modern Day "Fountain of Youth?" - October 31st, 2022 [March 4th, 2021]
- Declining Testosterone Levels in Men Not Part of Normal Aging - October 18th, 2021 [February 28th, 2021]
- Quick Weight Loss Tips and Diet Recommendations for HRT - October 21st, 2021 [February 28th, 2021]
- Testosterone and Alcohol: Your Health and the Holiday Season - October 18th, 2021 [February 27th, 2021]
- Testosterone builds muscle but has risks - February 25th, 2021 [February 25th, 2021]
- New Study Finds That Testosterone Does Not Increase Cardiovascular Risk - November 21st, 2021 [February 22nd, 2021]
- Evidence Suggests Testosterone Plays Powerful Role in Motivating Revolutionary Change - October 20th, 2021 [February 15th, 2021]
- The Effects of Parenthood Upon Testosterone Levels - November 27th, 2021 [January 9th, 2021]
- Testicular Cancer Survivors are at Risk for Low Testosterone - November 21st, 2021 [January 6th, 2021]
- Amygdala and it's Relationship to Testosterone and Fear - November 5th, 2021 [December 25th, 2020]
- Testosterone Does Not Cause Atherosclerosis (Hardening of the Arteries) in Older Men - November 3rd, 2021 [December 24th, 2020]
- Increased Testosterone DOES NOT Cause Prostate Cancer to Spread - October 19th, 2021 [December 23rd, 2020]
- Testosterone Cypionate and Testosterone Enanthate: The Real Facts - November 16th, 2021 [December 20th, 2020]
- A Surprising Side Effect of Methadone Treatment: Suppressed Testosterone - November 2nd, 2021 [December 18th, 2020]
- The Testosterone Industry Globally is Booming - November 12th, 2021 [December 12th, 2020]
- Five Benefits of Testosterone That You Need to Know - October 22nd, 2021 [December 11th, 2020]
- Testosterone Nasal Gel: A New Form of Testosterone Replacement Therapy - November 23rd, 2021 [December 5th, 2020]
- New Research Proves Testosterone Replacement Therapy is Safe for the Heart - October 31st, 2022 [December 3rd, 2020]
- Skinny Bartender with Low Testosterone Becomes a Ripped Bodybuilder - November 21st, 2021 [December 3rd, 2020]
- Low-T and Your Health - October 17th, 2021 [November 30th, 2020]
- Low Testosterone Levels may Affect Man's Sex Drive and Affect his Intimate Relationships - October 17th, 2021 [November 19th, 2020]
- Is Testosterone the New Drug of Choice on Wall Street? How Traders are Using Male Hormone Booster Shots to Maintain a ... - November 3rd, 2021 [November 12th, 2020]
- Shorter course of ADT for high-risk prostate cancer patients yields improved quality of life - November 11th, 2020 [November 11th, 2020]
- Testosterone Litigation: What You Need To Know - MTMP - Video - October 21st, 2021 [November 9th, 2020]
- Methadone Lowers Testosterone in Men Only - November 9th, 2020 [November 8th, 2020]
- Should middle-aged men consider 'low T' treatment? - November 6th, 2020 [November 5th, 2020]
- Testosterone and Crime: What Can Genes Tell Us About Behavior? - Video - October 25th, 2020 [October 25th, 2020]
- Testosterone shown to help sexually frustrated women - November 28th, 2021 [October 22nd, 2020]
- Testosterone levels seen prior to birth in fetus' fingers, jawline - November 18th, 2021 [October 20th, 2020]
- Tri-Blend Testosterone. Understanding the Benefits of Testosterone Oils - November 9th, 2021 [October 19th, 2020]
- Testosterone levels in older men - November 23rd, 2021 [October 17th, 2020]
- Tlando Testosterone Clinical Trial for Low-T and Fatty Liver Disease - October 29th, 2021 [October 4th, 2020]
- Testosterone Focus in Diabetes Study – Video - September 30th, 2020 [September 30th, 2020]
- Testshock Review All Natural Testosterone Enhancement – Video - September 30th, 2020 [September 30th, 2020]
- Testosterone, Anxiety, and Depression - November 19th, 2021 [September 30th, 2020]
- Average Testosterone Levels Decreasing Over Time Among Younger American Men - November 4th, 2021 [August 21st, 2020]
- Testosterone Creams for Low Testosterone Treatment and Andropause - November 14th, 2021 [August 10th, 2020]
- Testosterone Therapy and Androgen Deficiency Guide - November 29th, 2021 [August 6th, 2020]
- Testosterone's Surprising Link to Men's 'Love Hormone' Oxytocin - October 31st, 2022 [August 5th, 2020]
- Fortesta Brand Testosterone Therapy - November 28th, 2021 [August 3rd, 2020]
- Andropause: Age-Associated Testosterone Decline - October 26th, 2021 [August 1st, 2020]
- How to Build Muscle Quickly by Boosting Testosterone Levels - November 5th, 2021 [July 29th, 2020]
- Testosterone Deficiency Strongly Linked to Heart Attack Risk in New Study - October 16th, 2021 [July 26th, 2020]
- Seven Types of Drugs That Can Inhibit Sex Drive and Libido - October 23rd, 2021 [July 22nd, 2020]
- Testosterone and Geriatric Frailty - October 20th, 2021 [July 21st, 2020]
- Testosterone and Aggression: How T-Levels Impact Human Response to External, Social Threats - November 14th, 2021 [July 12th, 2020]
- High-Dose Testosterone Injections May Be a Viable Palliative Late-Stage Prostate Cancer Treatment - November 10th, 2021 [July 12th, 2020]
- Could Civilization Have Been Formed as a Result of Declining Testosterone Levels in Males? - November 4th, 2021 [July 6th, 2020]
- Testosterone Therapy Allows Man to Have the Body That He Was Meant to Have - November 11th, 2021 [July 5th, 2020]
- Testosterone Injections for Low-T and Andropause - November 5th, 2021 [July 4th, 2020]
- Testosterone Replacement Therapy (TRT) Reduces the Risk of Serious Adverse Health Consequences! - November 9th, 2021 [June 30th, 2020]
- Testosterone not always to blame - Sat, 04 Aug 2012 PST - November 14th, 2021 [June 28th, 2020]
- Five Facts About Testosterone (That Maybe You Didn't Know) - November 20th, 2021 [June 27th, 2020]
- Manhood Washed Away: You Could Unknowingly be Annihilating Your Testosterone - November 28th, 2021 [June 23rd, 2020]
- Testosterone: Should You Take it to Regain Your Libido and Youthful Energy? - November 18th, 2021 [June 22nd, 2020]
- Testosterone Replacement Therapy Boosts Aerobic Capacity - November 19th, 2021 [June 15th, 2020]
- Physiology of Testosterone - November 12th, 2021 [June 9th, 2020]
- The Truth Behind Common Male Sex Myths - November 19th, 2021 [May 26th, 2020]
Word Count: 645